A novel circular RNA, hsa_circ_0043278, acts as a potential biomarker and promotes non-small cell lung cancer cell proliferation and migration by regulating miR-520f

References

• Qin H, Wang F, Liu H, et al. New advances in immunotherapy for non-small cell lung cancer. Am J Transl Res. 2018;10:2234–2245.
   PubMed Web of Science ®Google Scholar
• Szejniuk WM, Robles AI, McCulloch T, et al. Epigenetic predictive biomarkers for response or outcome to platinum-based chemotherapy in non-small cell lung cancer, current state-of-art. Pharmacogenomics J. 2019;19(1):5–14.
   Web of Science ®Google Scholar
• Sui H, Ma N, Wang Y, et al. Anti-PD-1/PD-L1 therapy for non-small-cell lung cancer: toward personalized medicine and combination strategies. J Immunol Res. 2018;2018:1.
   Web of Science ®Google Scholar
• Reck M. Pembrolizumab as first-line therapy for metastatic non-small-cell lung cancer. Immunotherapy. 2018;10:93–105.
   PubMed Web of Science ®Google Scholar
• Nagano T, Tachihara M, Nishimura Y. Mechanism of resistance to epidermal growth factor receptor-tyrosine kinase inhibitors and a potential treatment strategy. Cells. 2018;7:212–227.
   PubMed Web of Science ®Google Scholar
• Beermann J, Piccoli MT, Viereck J, et al. Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches. Physiol Rev. 2016;96:1297–1325.
   PubMed Web of Science ®Google Scholar
• de Almeida RA, Fraczek MG, Parker S, et al. Non-coding RNAs and disease: the classical ncRNAs make a comeback. Biochem Soc Trans. 2016;44:1073–1078.
   PubMed Web of Science ®Google Scholar
• Slaby O, Laga R, Sedlacek O. Therapeutic targeting of non-coding RNAs in cancer. Biochem J. 2017;474:4219–4251.
   PubMed Web of Science ®Google Scholar
• Wei MM, Zhou GB. Long non-coding RNAs and their roles in non-small-cell lung cancer. Genomics Proteomics Bioinformatics. 2016;14:280–288.
   PubMed Web of Science ®Google Scholar
• Chen Y, Lu L, Feng B, et al. Non-coding RNAs as emerging regulators of epithelial to mesenchymal transition in non-small cell lung cancer. Oncotarget. 2017;8:36787–36799.
   PubMedGoogle Scholar
• Qu S, Yang X, Li X, et al. Circular RNA: a new star of noncoding RNAs. Cancer Lett. 2015;365:141–148.
   PubMed Web of Science ®Google Scholar
• Wang PL, Bao Y, Yee MC, et al. Circular RNA is expressed across the eukaryotic tree of life. PLoS One. 2014;9:e90859.
   PubMed Web of Science ®Google Scholar
• Wang X, Fang L. Advances in circular RNAs and their roles in breast cancer. J Exp Clin Cancer Res. 2018;37:206.
   PubMed Web of Science ®Google Scholar
• Xu N, Chen S, Liu Y, et al. Profiles and bioinformatics analysis of differentially expressed circrnas in taxol-resistant non-small cell lung cancer cells. Cell Physiol Biochem. 2018;48:2046–2060.
   PubMed Web of Science ®Google Scholar
• Osmani L, Askin F, Gabrielson E, et al. Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy. Semin Cancer Biol. 2018;52:103–109.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Huang SX, Zhang F, et al. MicroRNAs: a novel potential biomarker for diagnosis and therapy in patients with non-small cell lung cancer. Cell Prolif 2017;50(6):e12394.
   Web of Science ®Google Scholar
• Meng S, Zhou H, Feng Z, et al. CircRNA: functions and properties of a novel potential biomarker for cancer. Mol Cancer. 2017;16:94.
   PubMed Web of Science ®Google Scholar
• Ashwal-Fluss R, Meyer M, Pamudurti NR, et al. CircRNA biogenesis competes with pre-mRNA splicing. Mol Cell. 2014;56:55–66.
   PubMed Web of Science ®Google Scholar
• Shao Y, Li J, Lu R, et al. Global circular RNA expression profile of human gastric cancer and its clinical significance. Cancer Med. 2017;6:1173–1180.
   PubMed Web of Science ®Google Scholar
• Haque S, Harries LW. Circular RNAs (circRNAs) in health and disease. Genes (Basel). 2017;8(12):353.
   Web of Science ®Google Scholar
• Zhao Z, Li X, Jian D, et al. Hsa_circ_0054633 in peripheral blood can be used as a diagnostic biomarker of pre-diabetes and type 2 diabetes mellitus. Acta Diabetol. 2017;54:237–245.
   PubMed Web of Science ®Google Scholar
• Yan B, Zhang W, Mao XW, et al. Circular RNA ciRS-7 correlates with advance disease and poor prognosis, and its down-regulation inhibits cells proliferation while induces cells apoptosis in non-small cell lung cancer. Eur Rev Med Pharmacol Sci. 2018;22:8712–8721.
   PubMed Web of Science ®Google Scholar
• Hang D, Zhou J, Qin N, et al. A novel plasma circular RNA circFARSA is a potential biomarker for non-small cell lung cancer. Cancer Med. 2018;7:2783–2791.
   PubMed Web of Science ®Google Scholar
• Qu D, Yan B, Xin R, et al. A novel circular RNA hsa_circ_0020123 exerts oncogenic properties through suppression of miR-144 in non-small cell lung cancer. Am J Cancer Res. 2018;8:1387–1402.
   PubMed Web of Science ®Google Scholar
• Tian X, Zhang L, Jiao Y, et al. CircABCB10 promotes nonsmall cell lung cancer cell proliferation and migration by regulating the miR-1252/FOXR2 axis. J Cell Biochem. 2019:120(3):3765–3772.
   Web of Science ®Google Scholar
• Du X, Fan W, Chen Y. microRNA-520f inhibits hepatocellular carcinoma cell proliferation and invasion by targeting TM4SF1. Gene 2018;657:30–38.
   PubMed Web of Science ®Google Scholar
• Meshkat M, Mesrian Tanha H, Ghaedi K, et al. Association of a potential functional mir-520f rs75598818 G > A polymorphism with breast cancer. J Genet. 2018;97:1307–1313.
   PubMed Web of Science ®Google Scholar
• Hong S, Bi M, Chen S, et al. MicroRNA-520f suppresses growth of gastric carcinoma cells by target ATPase family AAA domain-containing protein 2 (ATAD2). Neoplasma. 2016;63:873–879.
   PubMed Web of Science ®Google Scholar